Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Virbac SA

VRBCF•PNK
Healthcare
Drug Manufacturers - General
$346.00
$-85.80(-19.87%)
U.S. Market opens in 8h 25m

Virbac SA (VRBCF) Stock Overview

Explore Virbac SA’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2.9B
P/E Ratio18.49
EPS (TTM)$20.31
ROE0.13%
Fundamental Analysis

AI Price Forecasts

1 Month$340.81
3 Months$313.98
1 Year Target$353.99

VRBCF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Virbac SA (VRBCF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 48.20, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $353.99.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 18.49 and a market capitalization of 2.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-19.87%
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
1.37%
3-Year Change
-13.50%
5-Year Change
34.11%
All-Time (Max) Change
396.06%

Contact Information

https://corporate.virbac.com
33 4 92 08 71 00
13e rue LID - BP 27, Carros, NaN, 06511

Company Facts

63,650 Employees
IPO DateApr 17, 2013
CountryFR
Actively Trading

Frequently Asked Questions